RecruitingNot ApplicableNCT06790264

Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer

Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer. a Phase II Study to Evaluate the Comparison of 68Ga-FAPi-46 and 18F-FDG Uptake in Patients with Different Breast Cancer Subtypes


Sponsor

European Institute of Oncology

Enrollment

92 participants

Start Date

Nov 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a prospective, non-interventional, open-label study to evaluate the glucose metabolism and the expression of the imaging agent 68 Gallium-Fibroblast Activation Protein Inhibitor-46 (68Ga-FAPi-46) with PET imaging, in woman affected by Breast Cancer (BC) and referred to diagnostic imaging work-up prior to primary therapy.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new type of PET scan called 68Ga-FAPi-46 PET/CT — which highlights the tissue surrounding tumors rather than the cancer cells themselves — to see how well it maps the environment around breast cancer tumors. This could help doctors better understand how each tumor behaves and plan more targeted treatments. **You may be eligible if...** - You are a woman aged 18 or older - You have newly diagnosed, biopsy-proven invasive breast cancer - Your tumor is larger than 2 centimeters - Your cancer involves the lymph nodes under your arm - You have already had or are scheduled to have a standard FDG PET/CT scan - You are a candidate for surgery or pre-surgery chemotherapy **You may NOT be eligible if...** - You are pregnant or breastfeeding - You cannot lie flat for the duration of a PET scan - Your biopsy tissue is unavailable for analysis - You have certain conditions that prevent participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURE68Ga-FAPi-46 PET/CT

Study participants will undergo baseline assessments at enrollment with 68Ga-FAPi-46 PET/CT


Locations(1)

European Institute of Oncology

Milan, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06790264


Related Trials